Posted in | News | Petrochemicals

Successful Start of S-Oil's Onsan Refinery Using ExxonMobil PxMax Process

ExxonMobil Chemical Technology Licensing LLC and S-Oil Corporation today announced the successful start-up of ExxonMobil's PxMax technology at S-Oil's Onsan refinery and chemical complex in South Korea. The PxMax process licensed by ExxonMobil and implemented at the Onsan refinery replaced a non-selective toluene disproportionation (TDP) process that produced equilibrium mixed xylenes. The selective nature of the PxMax process provides S-Oil with a paraxylene-enriched mixture that is further processed into sales grade paraxylene product at S-Oil's facility.

David Starkey, Global Xylenes Licensing Manager, ExxonMobil Chemical Technology Licensing LLC, said, "S-Oil is an important refiner and petrochemical producer in South Korea. We are very pleased that they have selected our PxMax technology to increase their overall paraxylene production and improve the cost-competitiveness of their Onsan refinery."

"We selected the ExxonMobil PxMax technology as one of a number of profit improvement activities focused on increasing paraxylene production capacity without modifying the paraxylene separation process facilities. The xylene product from the PxMax process is highly enriched in paraxylene which allows us to increase overall paraxylene production from the complex by almost 8 percent. The relatively simple retrofit of our existing TDP unit with PxMax offered us a way to quickly increase our paraxylene production and take advantage of the very favorable market conditions," said M. S. Seo, Refining Process Engineering Department General Manager, S-Oil.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.